Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 24 | 2023 | 127 | 4.470 |
Why?
|
| Cytochrome P-450 CYP1A1 | 18 | 2023 | 82 | 3.260 |
Why?
|
| Bronchopulmonary Dysplasia | 7 | 2020 | 184 | 1.930 |
Why?
|
| Lung Injury | 11 | 2023 | 118 | 1.910 |
Why?
|
| Acute Lung Injury | 9 | 2018 | 60 | 1.700 |
Why?
|
| beta-Naphthoflavone | 4 | 2017 | 10 | 1.620 |
Why?
|
| Cytochrome P-450 CYP1A2 | 11 | 2023 | 48 | 1.540 |
Why?
|
| Lung | 17 | 2023 | 1476 | 1.320 |
Why?
|
| Oxygen | 9 | 2023 | 549 | 1.150 |
Why?
|
| Animals, Newborn | 9 | 2018 | 1007 | 0.740 |
Why?
|
| Pulmonary Alveoli | 4 | 2017 | 139 | 0.690 |
Why?
|
| Infant, Premature | 5 | 2020 | 799 | 0.680 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 483 | 0.670 |
Why?
|
| Quercetin | 1 | 2018 | 5 | 0.610 |
Why?
|
| Oxidative Stress | 9 | 2021 | 798 | 0.600 |
Why?
|
| Cytochrome P-450 CYP1B1 | 4 | 2018 | 30 | 0.560 |
Why?
|
| Vitamin A Deficiency | 1 | 2016 | 13 | 0.530 |
Why?
|
| Vitamin A | 1 | 2016 | 59 | 0.520 |
Why?
|
| Conjunctival Diseases | 1 | 2016 | 31 | 0.510 |
Why?
|
| Optic Atrophy | 1 | 2016 | 46 | 0.500 |
Why?
|
| Receptors, Aryl Hydrocarbon | 7 | 2016 | 63 | 0.490 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2021 | 26 | 0.490 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 19 | 0.460 |
Why?
|
| Vision Disorders | 1 | 2016 | 212 | 0.450 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 582 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 4366 | 0.370 |
Why?
|
| Animals | 29 | 2023 | 33721 | 0.360 |
Why?
|
| Fetus | 1 | 2014 | 579 | 0.360 |
Why?
|
| Liver | 8 | 2015 | 1851 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2016 | 261 | 0.350 |
Why?
|
| Mice | 20 | 2023 | 17546 | 0.350 |
Why?
|
| Blotting, Western | 7 | 2017 | 1104 | 0.340 |
Why?
|
| Mice, Knockout | 12 | 2023 | 3770 | 0.340 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2023 | 135 | 0.310 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2023 | 65 | 0.300 |
Why?
|
| DNA Adducts | 3 | 2014 | 76 | 0.280 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8096 | 0.270 |
Why?
|
| Transcriptome | 3 | 2017 | 904 | 0.260 |
Why?
|
| Tretinoin | 1 | 2006 | 117 | 0.250 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 106 | 0.250 |
Why?
|
| Neutrophil Infiltration | 6 | 2015 | 65 | 0.230 |
Why?
|
| Sex Characteristics | 2 | 2017 | 308 | 0.220 |
Why?
|
| Nitric Oxide | 1 | 2006 | 438 | 0.210 |
Why?
|
| Rats | 6 | 2014 | 3657 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 1354 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 226 | 0.190 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 2534 | 0.180 |
Why?
|
| Omeprazole | 2 | 2011 | 98 | 0.180 |
Why?
|
| Adenoviridae Infections | 1 | 2000 | 69 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1296 | 0.170 |
Why?
|
| Methylcholanthrene | 2 | 2010 | 19 | 0.160 |
Why?
|
| Trachea | 1 | 2000 | 197 | 0.150 |
Why?
|
| Enzyme Induction | 4 | 2011 | 105 | 0.150 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 100 | 0.150 |
Why?
|
| Organ Size | 4 | 2015 | 411 | 0.140 |
Why?
|
| Humans | 19 | 2023 | 122296 | 0.140 |
Why?
|
| Pregnancy | 4 | 2023 | 7092 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 209 | 0.130 |
Why?
|
| Proteome | 1 | 2017 | 234 | 0.120 |
Why?
|
| DNA Damage | 1 | 2018 | 516 | 0.120 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 168 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 816 | 0.120 |
Why?
|
| Male | 14 | 2018 | 59522 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 2441 | 0.110 |
Why?
|
| Caffeine | 1 | 2014 | 69 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 492 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2015 | 394 | 0.110 |
Why?
|
| Female | 11 | 2023 | 64883 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 671 | 0.100 |
Why?
|
| Lipid Peroxidation | 3 | 2018 | 81 | 0.100 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 33 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1034 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 618 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3050 | 0.100 |
Why?
|
| Fish Oils | 1 | 2011 | 82 | 0.090 |
Why?
|
| Carcinogens | 1 | 2011 | 152 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2016 | 907 | 0.090 |
Why?
|
| Carcinogens, Environmental | 1 | 2010 | 16 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 276 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 1592 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A2 Inhibitors | 1 | 2006 | 3 | 0.070 |
Why?
|
| Body Weight | 3 | 2015 | 963 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2826 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1710 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4282 | 0.060 |
Why?
|
| Dinoprost | 2 | 2015 | 28 | 0.060 |
Why?
|
| Genes, Reporter | 3 | 2011 | 384 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1213 | 0.050 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 46 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 217 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1579 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12045 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 115 | 0.050 |
Why?
|
| Survival Rate | 1 | 2006 | 1997 | 0.050 |
Why?
|
| Sex Factors | 2 | 2015 | 1238 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 663 | 0.050 |
Why?
|
| Parvovirus | 1 | 2000 | 8 | 0.040 |
Why?
|
| Chlamydia | 1 | 2000 | 3 | 0.040 |
Why?
|
| Mycobacterium | 1 | 2000 | 29 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 479 | 0.040 |
Why?
|
| Luciferases | 2 | 2011 | 137 | 0.040 |
Why?
|
| Enterovirus | 1 | 2000 | 48 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2018 | 15 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1674 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 269 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2000 | 808 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2000 | 480 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2000 | 637 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 144 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 2782 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1277 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 1076 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 388 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 35 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 28 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 23 | 0.030 |
Why?
|
| Inflammation | 1 | 2002 | 1392 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2014 | 6 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 246 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 1703 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 51 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 379 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 583 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 475 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 4511 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 123 | 0.030 |
Why?
|
| Neutrophils | 1 | 2015 | 371 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 1579 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 3290 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 789 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 417 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 10 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2011 | 14 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2011 | 38 | 0.020 |
Why?
|
| Microsomes | 1 | 2011 | 56 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 51 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 317 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2525 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 530 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1679 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2011 | 92 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 312 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2011 | 337 | 0.020 |
Why?
|
| Apoproteins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 48 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2796 | 0.020 |
Why?
|
| Cytochromes | 1 | 2007 | 7 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2007 | 66 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2007 | 86 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1790 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 1106 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6182 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 2933 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1438 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 28733 | 0.010 |
Why?
|